---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-028711"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2024-06-04T23:59:59+00:00"
generated_at: "2026-06-01T06:30:39.288414+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sanuwave pays off $6.3M Celularity note for $2.075M, extends SEPA merger deadline to June 30

## Summary
- Paid $2.075 million to settle and extinguish a $6.3 million note and interest owed to Celularity from the 2020 UltraMist acquisition.
- Withdrew Nasdaq listing application due to bid price requirement; submitted application to Cboe BZX Exchange, currently under review.
- Extended SEPA merger outside date to June 30, 2024; Sanuwave received unilateral right to terminate the merger agreement at any time.
- Reaffirmed FY2024 revenue guidance above $30 million (50% growth) and Q2 2024 revenue growth of 45-55% versus Q2 2023.
- Capital raise from longtime shareholders funded the debt settlement; company believes it is sufficiently funded for remainder of 2024.

## SEC filing metadata
- accession: 0001140361-24-028711
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2024-06-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036124028711/0001140361-24-028711-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036124028711/ef20030490_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-028711
- JSON: https://secwatch.observer/filing/0001140361-24-028711.json
- Plain text: https://secwatch.observer/filing/0001140361-24-028711.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
